HK Stock MarketDetailed Quotes

06118 AUSTAR

Watchlist
  • 0.620
  • +0.010+1.64%
Market Closed Nov 29 16:08 CST
317.80MMarket Cap-4275P/E (TTM)

About AUSTAR Company

Aoxing Life Technology Co., Ltd. is a leading provider of high-end and integrated services and product engineering solutions in China, targeting well-known pharmaceutical companies and research institutes in China, as well as customers in emerging countries that provide these products and services. On November 7, 2014, the company was successfully listed on the main board of the Stock Exchange of Hong Kong Limited (stock code: 6118). AUSTAR Group was founded in 1991 and is headquartered in Beijing, China. Aoxing Group provides high-end integrated engineering solutions for customers to set up production facilities and build clean environments. Both are critical to pharmaceutical production. Aoxing Group's solutions cover fluid and bioprocess systems, clean rooms and automated control and monitoring systems, powder solids systems, and GMP compliance services, and can assist customers at key stages of the drug life cycle (from research, development, pilot plants, commercial production to product launch). We and our joint ventures are also engaged in the manufacture, sale and distribution of various high-end pharmaceutical equipment and life technology consumables. AUSTAR Group's value-added integrated engineering solutions are tailored to the customer to create part of the customer's production facilities. Aoxing Group assists customers in system construction and the use of hardware and software engineering and technology, including advice on system design, equipment selection, production processes, production technology applications and verification documents. Our solutions include providing equipment, parts, and advice on applied technologies that can improve the efficiency and efficiency of our customers' production processes. Through joint venture arrangements with STERIS and PALL, well-known companies in the life sciences industry, AUSTAR Group can use pharmaceutical equipment developed and/or produced by the joint venture partners and life science consumables developed and/or produced by the joint venture partners and joint ventures separately, to integrate these products into integrated engineering solutions and provide customers with a variety of high-quality products in the product portfolio based on complementary relationships with the joint venture partners.

Company Profile

Symbol06118
Company NameAUSTAR
ISINKYG0632L1023
Listing DateNov 7, 2014
Issue Price3.12
Shares Offered125.00M share(s)
FoundedJan 9, 2014
Registered AddressCayman Islands
Chairmanguoqiang he
Secretaryyujiao mai
Audit InstitutionDahua Ma Shiyun Certified Public Accountants Co., Ltd.
Company CategoryOther
Registered OfficeCricket Square, Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111 Cayman Islands
Head Office and Principal Place of BusinessRoom 6, 1st floor, New Trade Centre, 6 On Ping Street, Shatin, New Territories, Hong Kong
Fiscal Year Ends12-31
Employees1492
MarketHong Kong motherboard
Phone+852 26359880
Fax+852 26372499
Emailinfo@bj.austar.com.cn
Business Aoxing Life Technology Co., Ltd. is an investment holding company mainly engaged in providing integrated engineering solutions and manufacturing and distributing pharmaceutical equipment and consumables. The company operates six divisions: Fluid and Biological Process Systems Division; Clean Room and Automated Control and Monitoring Systems Division; Powder and Solids Systems Division; GMP Compliance Services Division; Life Science Consumables Division; and Pharmaceutical Equipment Distribution and Agency Division. The company's products include dust-free public engineering equipment and systems, biological process equipment and systems, powder and solid equipment and systems, pharmaceutical process pollution control products, packaging and sealed transportation products, biosafety and laboratory animal equipment and consumables, etc.

Company Executives

  • Name
  • Position
  • Salary
  • guoqiang he
  • Presidencies, CEO, Executive Director, Chairman of the Nomination Committee
  • 935.00K
  • jianhong he
  • Executive Director
  • 2.26M
  • yuewu chen
  • Executive Director, Member of the Risk Management Committee
  • 2.13M
  • ning zhou
  • Executive Director, Chairman of the Risk Management Committee, Remuneration Committee Members, Authorized Representative
  • 1.11M
  • lingling ji
  • Non-executive Directors, Audit Committee Members, Member of the Risk Management Committee
  • 632.00K
  • liji zhang
  • Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members, Remuneration Committee Members
  • 161.00K
  • kaishan zhao
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
  • 161.00K
  • kaijian liang
  • Independent Non-Executive Director
  • 161.00K
  • wei wang
  • VP
  • --
  • xiangdi tang
  • Chief Financial Officer, Vice President of Corporate Development
  • --
  • yujiao mai
  • Authorized Representative, Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data